CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use this state record to trace the legal requirement, then compare it with the terms an office adds. The full work explains the constitutional case, consent analysis, evidence needed, and protections to demand.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
Montana · Contract-for-Care evidence
What applies now, and what is only a policy or sample?
MT-R is the active registry statute. MT-I is the separate Medicaid layer. MT-G is clinical guidance. MT-X means an exact mandate was not established in the reviewed sources, not that a condition is unlawful or unnecessary. Current website policies, historical presentations and unassigned sample agreements have different evidence value.
MT-R · Active statute and terminated provision
MCA 37-7-1515 requires prescription-registry review before opioid or benzodiazepine prescribing, subject to exceptions. Those include hospice, a nonrefillable supply of seven days or less, administration in a facility, emergencies, qualifying technical failures, and chronic-pain care with review every three months. The statute’s chronic-pain review interval is not a universal monthly-visit, pill-count or drug-test rule.
The official 2025 code marks MCA 37-2-108 as terminated. Do not present its former initial-prescription restriction as a current statewide limit. Its termination does not erase separate payer edits or other prescribing duties.
MT-I · Medicaid coverage and targeted restrictions
The official Prescription Drug Program Manual, updated July 9, 2026, distinguishes payment limits from prescribing permission. Its refill section uses a 90%-elapsed threshold for listed controlled medications and permits limited early-refill approval for dosage changes or nursing-facility admission. Its prior-authorization section describes review and emergency-supply procedures. An office refill deadline is not interchangeable with those claim-processing conditions.
The September 10, 2026 Preferred Drug List, page 1, separately lists long-acting opioid quantity/MME restrictions and a one-long-acting-opioid limit. Consult current drug-specific criteria through the pharmacy portal; a coverage restriction is not a universal prescribing maximum.
For targeted treatment contracts, Cornell’s reproduction of ARM 37.86.1103(12) describes possible screening, pill counts and a one-prescriber treatment contract after professional review determines inappropriate use. This is a conditional Medicaid restriction, not proof that every Montana patient must sign every private clause. The official rule endpoint could not be retrieved during this review; verify its current text before relying on that subsection. This source limitation is retained explicitly.
The April 19, 2024 provider notice removed the extra opioid prior-authorization requirement based on a history of medication for opioid use disorder while preserving universal opioid edits. It did not remove all opioid authorization requirements.
MT-G · Clinical guidance is not an automatic mandate
The CDC 2022 guideline cautions against inflexible dosage standards and rapid tapering or abrupt discontinuation except where a life-threatening issue warrants it. Its recommendations have defined patient and setting limits. Historical slide descriptions of 2016 guidance are not substituted for today’s guidance or Montana law. A medication holiday described on a clinic webpage is not proof of a legally required procedure.
MT-X · Exact requirement not established
Ask who requires the specific deadline, fee, disclosure, service or consequence, and what exceptions apply. This label is an inference from a focused review, not a finding of illegality. Nursing standards, workers’ compensation, federal or tribal systems, insurer terms and individual clinical circumstances may impose other duties. No full current office-specific opioid agreement was established for the listed offices.
Document register
- Providence scheduling policy and 14-page intake questionnaire: intake requirements, not a complete opioid agreement.
- Montana Headache Clinic general agreement: three pages, 2024 filename; currently linked by the practice.
- Logan Health service webpage: public treatment descriptions; no proof of universal application.
- Benefis Pain Clinic presentation: 16 slides hosted by ACP, undated in reviewed text and referring to 2016 guidance; historical, current branch adoption unknown.
- Six-page Pain Agreement template from the Know Your Dose / MMA toolkit: May 2015 upload path; no listed office adoption established.
Reviewed October 13, 2026, America/Chicago. Sources remain with their publishers. No practice was contacted.